Intended for healthcare professionals

CCBYNC Open access

Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

BMJ 2019; 365 doi: (Published 03 April 2019) Cite this as: BMJ 2019;365:l1161

Linked editorial

The remarkable impact of bivalent HPV vaccine in Scotland

Linked opinion

Bivalent HPV vaccine in Scotland is having a considerable and sustained effect